普列克底物蛋白2/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制研究

王蔓莉, 陈辉, 段智, 许奇美, 李贞

  1. 长沙市第一医院(中南大学湘雅医学院附属长沙医院)病理科,湖南 长沙 410005
  • 收稿日期:2023-11-17 修回日期:2024-02-27 出版日期:2024-07-30 发布日期:2024-08-08
  • 通信作者: 陈辉
  • 作者简介:王蔓莉(ORCID: 0009-0009-7269-8181),硕士,主治医师。
  • 基金资助:
    湖南省卫生健康委科研项目(AGFJ2021347)

摘要/Abstract

摘要:

背景与目的:阐明介导肿瘤相关成纤维细胞(cancer-associated fibroblasts,CAFs)与肿瘤细胞之间通讯的信号分子仍然是一个巨大的挑战,这些信号分子对癌症转移至关重要。本研究旨在探讨普列克底物蛋白2(pleckstrin-2,PLEK2)/miR-196a信号轴介导肿瘤微环境中肺癌细胞的通讯机制。方法:选择人肺腺癌细胞系H1299和人胚胎肺细胞MRC-5作为研究对象。用表达PLEK2的慢病毒(PLEK2)和载体对照(Vector)转染H1299细胞,并在转染24 h后分离外泌体(Vector_exo、PLEK2_exo)。采用miR-196a模拟物或抑制剂转染MRC-5细胞。通过蛋白质印迹法(Western blot)分析PLEK2和上皮-间充质转化(epithelial-mesenchymal transition,EMT)相关蛋白水平,采用聚合酶链反应(polymerase chain reaction,PCR)分析miR-196a表达,采用transwell实验测定细胞转移和侵袭能力。将6只雌性BALB/c-nu小鼠随机分为Vector组和PLEK2组,每组3只。通过尾静脉向各组小鼠注射转染Vector或PLEK2的H1299细胞。4周后,取出肺组织进行H-E染色和免疫组织化学染色分析α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)表达。所有动物实验均经长沙市第一医院(中南大学湘雅医学院附属长沙医院)伦理委员会批准(伦理编号为EI-2021-103)。结果:与Vector组相比,PLEK2组小鼠肺结节数和转移灶中α-SMA表达显著增加(P<0.001)。与Vector组相比,PLEK2组H1229细胞中miR-196a表达水平显著增加(P<0.05),并且PLEK2_exo中miR-196a表达水平显著高于Vector_exo(P<0.05)。与Vector_exo组相比,PLEK2_exo组MRC-5细胞中miR-196a、α-SMA和成纤维细胞活化蛋白(fibroblast activation protein,FAP)表达水平显著增加(P <0.05)。与阴性对照(negative control,NC)相比,miR-196a转染的MRC-5细胞中α-SMA和FAP表达水平显著增加(P<0.05)。相反,通过miR-196a抑制剂(si-miR-196a#1、si-miR-196a#)转染,α-SMA和FAP表达水平被显著抑制(P<0.05)。与NC-CM组相比,miR-196a-CM组H1299细胞的转移、侵袭细胞数和波形蛋白(vimentin)表达均显著增加(P<0.001),E-钙黏蛋白(E-cadherin)表达显著降低(P<0.001)。此外,与Vector_exo-CM组相比,PLEK2_exo-CM组H1299细胞的转移、侵袭细胞数和vimentin表达均显著增加(P<0.01),E-cadherin表达显著降低(P<0.001)。结论:PLEK2上调能够增强肺癌细胞来源的外泌体miR-196a水平,从而促进CAFs激活。激活的CAFs能够进一步增强肺癌细胞的侵袭能力。

关键词: 普列克底物蛋白2, 肿瘤微环境, 肺癌细胞, 肿瘤相关成纤维细胞

Abstract:

Background and purpose: It is still a great challenge to clarify the signal molecules that mediate the communication between cancer-associated fibroblasts (CAFs) and tumor cells. These signal molecules are very important for cancer metastasis. The purpose of this study was to explore the communication mechanism of pleckstrin-2/miR-196a signal axis mediated by lung cancer cells in tumor microenvironment. Methods: Human lung adenocarcinoma cell line H1299 and human embryonic lung cell MRC-5 were selected as the research objects. H1299 cells were transfected with lentivirus (PLEK2) expressing PLEK2 and Vector control, and exosomes (Vector_exo, PLEK2_exo) were isolated after 24 h of transfection. MRC-5 cells were transfected with miR-196a mimetic or inhibitor. The expressions of PLEK2 and epithelial-mesenchymal transition (EMT)-related proteins were analyzed by Western blot. The expression of miR-196a was analyzed by polymerase chain reaction (PCR), and the metastasis and invasion ability of cells were determined by transwell assay. Six female BALB/c-nu mice were randomly divided into Vector group and PLEK2 group, with 3 mice in each group. Mice in each group were injected with H1299 cells transfected with Vector or PLEK2 through the tail vein. After 4 weeks, lung tissue was taken out for H-E staining and immunohistochemical staining to analyze the expression of α-smooth muscle actin (α-SMA). All animal experiments were approved by the ethics committee of First Hospital of Changsha City (Changsha Hospital, Xiangya School of Medicine, Central South University) (ethics number: EI-2021-103). Results: Compared with the Vector group, the number of pulmonary metastatic nodules and the expression of α-SMA in metastatic cancer in PLEK2 group increased significantly (P<0.001). Compared with Vector group, the expression level of miR-196a in H1229 cells in PLEK2 group increased significantly (P<0.05), and the expression level of miR-196a was significantly higher in PLEK2_exo than in Vector_exo (P<0.05). Compared with Vector_exo group, the expression levels of miR-196a, α-SMA and fibroblast activation protein (FAP) in MRC-5 cells in PLEK2_exo group increased significantly (P<0.05). Compared with the negative control (NC), the expression levels of α-SMA and FAP in MRC-5 cells transfected with miR-196a increased significantly (P<0.05). On the contrary, by transfection with miR-196a inhibitors (si-miR-196a#1 and si-miR-196a#), the expression levels of α-SMA and FAP were significantly inhibited (P<0.05). Compared with NC-CM group, the number of metastatic cells, invasive cells and the expression of vimentin in miR-196a-CM group increased significantly (P<0.001), and the expression of E-cadherin decreased significantly (P<0.001). In addition, compared with Vector_exo-CM group, PLEK2_exo-CM group had significant increase in number of metastatic and invasive cells and the expression of vimentin (P<0.01), and significant decrease in the expression of E-cadherin (P<0.001). Conclusion: Upregulation of PLEK2 can enhance the level of exosomes miR-196a derived from lung cancer cells, thereby promoting the activation of CAFs. The activated CAFs can further enhance the invasive ability of lung cancer cells.

Key words: Pleckstrin-2, Tumor microenvironment, Lung cancer cells, Cancer-associated fibroblasts

中图分类号: 

相关文章

[1] 王小聪, 李明. 单细胞测序在口腔鳞状细胞癌研究中的价值[J]. 中国癌症杂志, 2024, 34(5): 501-508.
[2] 张少秋, 燕丽, 李瑞辰, 赵阳, 王孝深, 杨旭光, 朱奕. 头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望[J]. 中国癌症杂志, 2023, 33(6): 629-636.
[3] 薛影, 毛蕴玉, 徐建青. 用于实体瘤治疗的缺氧敏感型CAR-T细胞的研究进展[J]. 中国癌症杂志, 2023, 33(1): 71-77.
[4] 刘强, 方仪, 王靖. 单细胞测序技术在乳腺癌研究中的应用进展[J]. 中国癌症杂志, 2022, 32(7): 635-642.
[5] 宿佳琦, 徐文浩, 田熙, 艾合太木江·安外尔, 瞿元元, 施国海, 张海梁, 叶定伟. 肾透明细胞癌联合免疫治疗新策略——有氧糖酵解的研究进展及展望[J]. 中国癌症杂志, 2022, 32(4): 287-297.
[6] 周术奎, 张东亮, 王翔, 刘磊, 李曾, 杨盛柯, 廖洪. 利用细胞膜片技术构建新型前列腺癌皮下移植瘤动物模型[J]. 中国癌症杂志, 2022, 32(3): 200-206.
[7] 李 崴, 张山岭, 陶英杰, 王旭东. T细胞免疫代谢调控与免疫检查点抑制剂联合应用的现状及研究进展[J]. 中国癌症杂志, 2021, 31(7): 640-646.
[8] 乔婷婷, 葛淑静, 罗 渊, 陆承荣, 段连宁 . H2AX磷酸化抑制肺癌细胞发生上皮-间质转化的作用机制[J]. 中国癌症杂志, 2021, 31(4): 277-284.
[9] 韩香臣, 李小光, 胡 欣. 单细胞转录组测序及其在乳腺癌中的应用[J]. 中国癌症杂志, 2021, 31(11): 1110-1114.
[10] 魏丽荣 , 滕小艳 , 夏前林 , 杜玉珍 . STC1诱导上皮-间质转化促进肺癌细胞的侵袭和迁移[J]. 中国癌症杂志, 2020, 30(7): 497-504.
[11] 蒋梦怡 , 陆言巧 , 王红霞 . 乳腺癌异质性的研究进展及临床意义[J]. 中国癌症杂志, 2020, 30(5): 394-400.
[12] 范守仁, 吴淑华, 李扬扬, 许晓阳, 何 双, 温菲菲, 刘 柳, 郭宁杰, 贾真真 . 结直肠癌中LC3与不同表型肿瘤相关巨噬细胞的相关性及其临床意义[J]. 中国癌症杂志, 2020, 30(11): 849-857.
[13] 金宇娟, 胡 良, 季红斌. 肺癌发病分子机理研究新进展:从基础到临床[J]. 中国癌症杂志, 2020, 30(10): 759-769.
[14] 方瑜佳, 周 娟, 苏春霞. 非小细胞肺癌肝转移免疫微环境及未来干预策略[J]. 中国癌症杂志, 2020, 30(10): 750-758.
[15] 杨云松, 江一舟, 胡 欣, 邵志敏. 乳腺肿瘤微环境靶向治疗的研究进展[J]. 中国癌症杂志, 2019, 29(12): 977-984.